13.10.2016 18:06:45

Press Release: Invitation to discuss Actelion's nine months results 2016

Actelion Pharmaceuticals Ltd / Invitation to discuss Actelion's nine months results 2016 . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement.

Dear member of the investment community,

Actelion Ltd will announce its financial results for the first nine months of 2016 on Thursday, 20 October 2016, at 07:00 hrs CEST.

An investor conference call and webcast will be held at 13:00 hrs CEST to discuss the results.

To support your preparations, consensus estimates can be found under www.actelion.com/consensus-estimate

Date/Time:

20 October 2016 13:00 hrs - 14:00 hrs Basel 12:00 hrs - 13:00 hrs London 07:00 hrs - 08:00 hrs New York

Conference Call Connect #:

Dial-in participants should start calling the number below 10-15 minutes before the conference is due to start.

Dial: Europe: +41 (0)44 583 18 01 UK: +44 (0)203 009 24 60 US: +1 855 402 77 67

Participant's mode:

Listen-Only with possibility to open individual lines during Q&A session. Participants will be asked for their name and company.

Webcast Access:

Webcast participants should go to the Actelion website http://www.actelion.com 10-15 minutes before the conference is due to start.

Participant's mode: Listen-Only

Webcast Replay:

The archived Investor Webcast will be available for replay through http://www.actelion.com / approximately 60 minutes after the call has ended.

Invitation Conference Call/Webcast PDF: http://hugin.info/131801/R/2048638/765988.pdf

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Actelion Pharmaceuticals Ltd via Globenewswire

--- End of Message ---

Actelion Pharmaceuticals Ltd

Gewerbestrasse 16 Allschwil Switzerland

ISIN: CH0010532478;

http://www.actelion.com (END) Dow Jones Newswires

   October 13, 2016 11:35 ET (15:35 GMT)- - 11 35 AM EDT 10-13-16

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Nachrichten zu Actelion Ltd.mehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Actelion Ltd.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Indizes in diesem Artikel

NASDAQ Comp. 20 041,26 0,07%